Literature DB >> 32014535

Long-term (24h) cooling of ovarian fragments in the presence of permeable cryoprotectants prior to freezing: Two unsuccesful IVF-cycles and spontaneous pregnancy with baby born after re-transplantation.

Vladimir Isachenko1, Bernd Morgenstern2, Plamen Todorov3, Evgenia Isachenko2, Peter Mallmann2, Bettina Hanstein2, Gohar Rahimi2.   

Abstract

Cancer is the second major cause of death in the world. The problem of post-cancer infertility plays a significant role, because chemotherapy can be gonadotoxic. Cryopreservation of ovarian tissue before cancer therapy with re-implantation after convalescence is the potential key solution to this problem. The aim of this study was to test the viability of cryopreserved human ovarian cortex after long-term cooling in culture medium composed of permeable cryoprotectants. Ovarian fragments from sixteen patients were randomly divided into two groups. After the operation, tissue pieces assigned to both groups were cooled to 5 °C for 22-24 h, frozen and thawed. Group 1 pieces (n = 32) were cooled before cryopreservation in the standard culture medium, and Group 2 pieces (n = 32) were cooled in the freezing medium (culture medium+6% ethylene glycol+6% dimethyl sulfoxide+0.15 M sucrose). Freezing was performed in standard 5 ml cryo-vials with ice formation at -9 °C, cooling from -9 to -34 °C at a rate of -0.3 °C/min and plunging at -34 °C into liquid nitrogen. After thawing in a 100 °C (boiling) water bath, the removal of cryoprotectants was performed in 0.5 M sucrose with 20 min exposure in sucrose and 30 min stepping rehydration. The effectiveness of the pre-freezing cooling of tissue was evaluated by the development of follicles (histology). Six months after the autotransplantation, oocytes from the twenty-seven-year old, hormonally stimulated patient were retrieved and fertilized with her partner sperm through the intracytoplasmic spermatozoa injection (ICSI). For groups 1 and 2, 93.5 ± 1.9% and 96.4 ± 2.0% of the preantral follicles, respectively, were morphologically normal (P > 0.1) (with a tendency toward increasing in quality in Group 2). Six months after the auto-transplantation, two ICSI cycles resulted in the gathering and transplantation of high quality embryos, but no pregnancy had been established. Thirteen months after the auto-transplantation, the patient became spontaneously pregnant and delivered a healthy baby girl at term. Long-term (24 h) cooling of ovarian tissue to 5 °C before cryopreservation in the presence of permeable cryoprotectants simplifies the protocol of cryopreservation and has a tendency of increasing of the cells viability after thawing.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baby born; Cancer; Cooling; Cryoprotectants; Freezing; Human ovarian tissue; In vitro culture

Year:  2020        PMID: 32014535     DOI: 10.1016/j.cryobiol.2020.01.022

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  3 in total

1.  Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data.

Authors:  Kutluk Oktay; Loris Marin; Giuliano Bedoschi; Fernanda Pacheco; Yodo Sugishita; Tai Kawahara; Enes Taylan; Carlo Acosta; Heejung Bang
Journal:  Fertil Steril       Date:  2021-11-17       Impact factor: 7.329

2.  Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue.

Authors:  Vladimir Isachenko; Bernd Morgenstern; Plamen Todorov; Evgenia Isachenko; Peter Mallmann; Bettina Hanstein; Gohar Rahimi
Journal:  J Ovarian Res       Date:  2020-09-29       Impact factor: 4.234

3.  New method of FACS analyzing and sorting of intact whole ovarian fragments (COPAS) after long time (24 h) cooling to 5 °C before cryopreservation.

Authors:  Wanxue Wang; Mahmoud Salama; Plamen Todorov; Dimirtry Spitkovsky; Evgenia Isachenko; Rico Bongaarts; Gohar Rahimi; Peter Mallmann; Gennady Sukhikh; Vladimir Isachenko
Journal:  Cell Tissue Bank       Date:  2021-01-24       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.